VERU vs. NVAX

In the year-to-date period, VERU achieves a -16.57% return, which is significantly higher than NVAX's -27.11% return. Over the past 10 years, VERU has outperformed NVAX with an annualized return of -16.63%, while NVAX has yielded a comparatively lower -28.43% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Veru Inc. (VERU) and Novavax, Inc. (NVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VERU Sharpe Ratio is -0.49, which is lower than the NVAX Sharpe Ratio of 0.26. The chart below compares the historical Sharpe Ratios of VERU and NVAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither VERU nor NVAX has paid dividends to shareholders.

The maximum VERU drawdown since its inception was -98.44%, roughly equal to the maximum NVAX drawdown of -98.82%. Use the drawdown chart below to compare losses from any high point for VERU and NVAX. For additional features, visit the drawdowns tool.

Veru Inc. (VERU) has a higher volatility of 35.39% compared to Novavax, Inc. (NVAX) at 31.26%. This indicates that VERU's price experiences larger fluctuations and is considered to be riskier than NVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Veru Inc. and Novavax, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.